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INTRODUCTION: The vimentin cytoskeleton 
is believed to facilitate extracellular signal 
transduction inducing transcriptional responses 
within the chondrocyte. The spatial 
organisation of vimentin differs in human 
osteoarthritic chondrocytes, and a reduction in 
vimentin protein was observed in a rat model of 
osteoarthritis. The aim of this study was to 
assess the role of the vimentin filaments on 
cartilage chondrocyte homeostasis. 
 
METHODS: Chondrocytes from 7-day-old 
bovine articular cartilage were plated at 
1x106cells/24 well plate, and vimentin filaments 
disrupted with 1-5mM acrylamide for 24, 48 
and 72hrs.  Disruption of the vimentin filaments 
was confirmed using a FITC-conjugated 
vimentin antibody visualized using confocal 
microscopy. The cytotoxic effects of 
acrylamide were assessed using the CytoTox® 
96 assay. Changes in phenotypic markers of 
chondrocytes i.e. type II collagen and sGAG 
were measured by immunoblotting and DMMB 
assay, respectively. The amount of 
phosphorylated versus total MAP kinase 
proteins (ERK 1/2, p38 and JNK) was also 
conducted by immunoblotting. Specific MAP 
kinase inhibitors (U0126, SB203580 and 
SP600125 respectively) were added to 
chondrocyte cultures in the presence of 
acrylamide to determine the involvement of 
each in vimentin-mediated signal transduction.   
 
RESULTS: In the presence of acrylamide, the 
vimentin filaments were observed to collapse 
around the nuclei, whereas the filaments in 
control cells were organized into a dense 
network throughout the cytoplasm. Acrylamide 
was cytotoxic in a dose-dependent manner, 
which was significant after 72 hours in culture. 
Hence, all other data are normalized to cell 
number. Levels of sGAG in the media 
decreased with increasing acrylamide 
concentrations. This was also evident with pro 
type II collagen expression; interestingly, 
disruption of vimentin inhibited the processing 
of the pro-collagen into the II (α1) chains. An 
increase in phosphorylated ERK 1/2 was 
observed with increasing acrylamide 
concentration. Preliminary data indicates that 
increased phosphorylation of ERK 1/2 
correlates with a change in chondrocyte 
phenotype. There were minimal effects on 
phosphorylated p38 kinase and JNK in 
acrylamide treated chondrocytes. We are 
currently analyzing the effect of blocking ERK 
phosphorylation using specific inhibitors to 
determine whether this prevents the change in 
phenotype. 
 
DISCUSSION & CONCLUSIONS: We have 
shown that cytoskeletal vimentin element 
modulation by disruption with acrylamide alters 
the phenotype of the chondrocyte. ERK 
phosphorylation is widely reported to inhibit 
chondrogenesis1,2, therefore we believe that 
disassembly of the vimentin architecture, by an 
as yet unknown mechanism, results in 
phosphorylation of ERK 1/2 which may alter 
the phenotype of the chondrocyte i.e. inhibits 
sGAG and type II collagen production. We are 
currently determining the mechanism(s) 
involved in mediating these matrix changes, 
and the role of the chondrocyte cytoskeleton in 
signal transduction, changes in which may 
contribute to joint pathologies such as 
osteoarthritis. 
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